Utility and Patient Preference Studies
Utilities are an increasingly important measure of health status both as input to health economic modeling and as stand-alone health state values. Several key healthcare markets now require manufacturers to demonstrate cost effectiveness as part of their reimbursement process, ensuring that utility measurement is now an essential part of many submissions.
Oxford Outcomes is a market leader in utility elicitation and patient preference studies. We integrate expertise from our core disciplines: Health Economics and Patient Reported Outcomes to provide these services. With our strong scientific foundations in PRO research and Health Economics, Oxford Outcomes is uniquely able to design utility, utility mapping and cross-walk studies that optimize scientific validity, sensitivity to health state differences and the methodological rigor required for economic evaluation. Oxford Outcomes has expertise in a range of utility and mapping methods to meet the requirements of national and regional reimbursement agencies such as NICE, SMC, CDR, and PBAC. Visit our team and publications pages for further information.
Oxford Outcomes can add value to reimbursement submissions by assessing at an early stage, the validity and sensitivity of published utility data and, if necessary, design studies that will capture all of the benefits of treatment and maximize the chance of demonstrating cost effectiveness. Reimbursement agencies play close attention to the quality of the utility data used in reimbursement submissions, and the number of rejected submissions based on poorly-founded utility values is testimony to this trend.